John J.P. Kastelein - Concepedia

Author

John J.P. Kastelein

Amsterdam UMC Location University of Amsterdam ORCID

Also Known As

Berit Johansen, Daniel F Freitag, E De Groot, Folkert W Asselbergs, G. Kees Hovingh, Gunnar Olsson, Hiroshi Mabuchi, J J Kastelein, J J P Kastelein, J JP Kastelein

1.1K

Publications

135.6K

Citations

165

H-Index

206

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University of Amsterdam Leiden University Medical Center University of British Columbia University of Cambridge

About

John J.P. Kastelein is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	79	222	28.5K
2	Health Sciences	20	25	3K
3	Natural Sciences	8	8	577
4	Engineering	4	4	133
5	Management	1	1	17

John J.P. Kastelein

560

Publications

98.7K

Citations

144

H-Index

Page 1

	Year	Citations
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Paul M. Ridker, Tom Thurén, Jean MacFadyen, New England Journal of Medicine	2017	8.7K
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, New England Journal of Medicine	2008	6.5K
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Obstetrical & Gynecological Survey Vascular DiseaseElevated C-reactive ProteinUnstable AnginaHyperlipidemiaPharmacotherapy	2009	3.7K
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease John C. LaRosa, Scott M. Grundy, David D. Waters, New England Journal of Medicine	2005	3.5K
Effects of Torcetrapib in Patients at High Risk for Coronary Events Philip J. Barter, Mark J. Caulfield, Mats Eriksson, New England Journal of Medicine	2007	3.1K
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events Jennifer G. Robinson, Michel Farnier, Michel Krempf, New England Journal of Medicine	2015	2.3K
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Angela Brooks‐Wilson, Michel Marcil, Susanne M. Clee, Nature Genetics Mendelian DisorderDisease MechanismGenetic DisorderMedicineGenetics	1999	1.7K
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events Philip J. Barter, Antonio M. Gotto, John C. LaRosa, New England Journal of Medicine	2007	1.6K
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol Kausik K. Ray, R. Scott Wright, David Kallend, New England Journal of Medicine	2020	1.4K
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Paul M. Ridker, Jean MacFadyen, Tom Thurén, The Lancet InflammationAllergyLung InflammationMedicineMetronomic Therapy	2017	1.3K

Page 1